THINK Surgical Marks TMINI System Procedure Milestone

THINK Surgical Inc.’s TMINI Miniature Robotic System has been used in more than 500 total knee arthroplasty (TKA) procedures in the United States, the company announced.

“Achieving this 500-case milestone so quickly demonstrates the market’s eagerness to adopt our miniature, handheld, wireless robot,” THINK Surgical President/CEO Stuart Simpson said. “Surgeon and hospital staff using the TMINI System are reporting that they enjoy it because of its accuracy and efficiency in the OR. We are excited about our new customer pipeline and look forward to seeing many more successful TKA procedures  completed with the TMINI Robot.”

There currently are nine U.S. Food and Drug Administration (FDA) 510(k)-cleared implant partners from which to choose. The company claims its TMINI System not only has the most implant systems and design philosophies available of any robotic system, but is also the only miniature, handheld, wireless robot currently available in the United States.

The TMINI Miniature Robotic System initially received FDA 510(k) clearance in May 2023 with a single implant partner. It has since received multiple clearances for the TMINI 1.1 Version Update that enables the TMINI PRO Workflow, enabling implant positional refinement and optimization, and eight additional implant partners by November 2024. The TMINI Miniature Robotic System is commercially available throughout the United States.

THINK Surgical Inc., is a privately held U.S.-based technology innovator that develops and markets orthopedic robots. THINK Surgical robots are open platforms providing support for implant brands from multiple manufacturers, enabling the choice of implant to be driven by the surgeon. THINK Surgical actively collaborates with healthcare professionals worldwide to refine its products, improving the lives of those suffering from advanced joint disease.